Amwell (AMWL) Misses Q4 EPS by 73c

Amwell (NYSE: AMWL) reported Q4 EPS of ($0.99), $0.73 worse than the analyst estimate of ($0.26). Revenue for the quarter came in at $79.2 million versus the consensus estimate of $78.08 million.

For earnings history and earnings-related data on Amwell (AMWL) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• BIG3 Basketball to go public via Graf Global merger at $290 million
• The Lovesac Company (LOVE) Tops Q1 EPS by 29c